154 related articles for article (PubMed ID: 18435781)
1. The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial.
Del Prato S; Blonde L; Martinez L; Göke B; Woo V; Millward A; Gomis R; Canovatchel B; Strack T; Lawrence D; Freemantle N;
Diabet Med; 2008 Jun; 25(6):662-70. PubMed ID: 18435781
[TBL] [Abstract][Full Text] [Related]
2. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
[TBL] [Abstract][Full Text] [Related]
3. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
4. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.
Bretzel RG; Nuber U; Landgraf W; Owens DR; Bradley C; Linn T
Lancet; 2008 Mar; 371(9618):1073-84. PubMed ID: 18374840
[TBL] [Abstract][Full Text] [Related]
5. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
[TBL] [Abstract][Full Text] [Related]
6. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
8. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
[TBL] [Abstract][Full Text] [Related]
9. Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes.
Hollander PA; Cefalu WT; Mitnick M; Lawrence D; Rosenstock J
Diabetes Technol Ther; 2010 Mar; 12(3):185-91. PubMed ID: 20151768
[TBL] [Abstract][Full Text] [Related]
10. Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096).
Ratner R; Wynne A; Nakhle S; Brusco O; Vlajnic A; Rendell M
Diabetes Obes Metab; 2011 Dec; 13(12):1142-8. PubMed ID: 21812890
[TBL] [Abstract][Full Text] [Related]
11. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
[TBL] [Abstract][Full Text] [Related]
12. Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice.
Ligthelm RJ
Prim Care Diabetes; 2009 May; 3(2):97-102. PubMed ID: 19285933
[TBL] [Abstract][Full Text] [Related]
13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
14. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
[TBL] [Abstract][Full Text] [Related]
15. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
[TBL] [Abstract][Full Text] [Related]
16. Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents.
Wolffenbuttel BH; Klaff LJ; Bhushan R; Fahrbach JL; Jiang H; Martin S
Diabet Med; 2009 Nov; 26(11):1147-55. PubMed ID: 19929994
[TBL] [Abstract][Full Text] [Related]
17. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.
van Dieren S; Kengne AP; Chalmers J; Beulens JW; Davis TM; Fulcher G; Heller SR; Patel A; Colagiuri S; Hamet P; Mancia G; Marre M; Neal B; Williams B; Peelen LM; van der Schouw YT; Woodward M; Zoungas S
Diabetes Obes Metab; 2014 May; 16(5):426-32. PubMed ID: 24251579
[TBL] [Abstract][Full Text] [Related]
18. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
19. Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.
Kvapil M; Swatko A; Hilberg C; Shestakova M
Diabetes Obes Metab; 2006 Jan; 8(1):39-48. PubMed ID: 16367881
[TBL] [Abstract][Full Text] [Related]
20. Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera).
Norwood P; Dumas R; Cefalu W; Yale JF; England R; Riese R; Teeter J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2211-4. PubMed ID: 17003088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
